Catalyst Wire Dossier Catalyst Wire Dossier

Piperacillin Sodium and Sulbactam Sodium for Injection (2:1)

piperacillin and sulbactam · Xiangbei Welman Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Piperacillin Sodium and Sulbactam Sodium for Injection (2:1), covering 2013-07-12 to 2019-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection [Phase 4]

See pricing